May 2, 2018 / 6:51 AM / 2 months ago

BRIEF-Novo Nordisk CEO: New Ozempic Drug To Reach At Least DKK 1 Billion Sales In 2018

May 2 (Reuters) - NOVO NORDISK A/S CEO LARS FRUERGAARD JORGENSEN SAID AT CALL AFTER Q1 EARNINGS:

* SALES OF OZEMPIC DIABETES DRUG IS EXPECTED TO REACH AT LEAST DKK 1 BILLION IN 2018

* VICTOZA DIABETES DRUG STILL LOSING MARKET SHARE TO ELI LILLY'S TRULICITY, ALBEIT AT LOWER PACE FURTHER COMPANY COVERAGE: (Reporting by Stine Jacobsen)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below